Special Issue "Current and Emerging Treatment Options in Cognitive Decline and Neurocognitive Disorders"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: 20 July 2023 | Viewed by 1947
Special Issue Editor

Interests: Alzheimer's disease (AD); mild cognitive impairment (MCI); clinical trial
Special Issue Information
Dear Colleagues,
Brain aging is one of the most tremendous deteriorations during aging. An aberrant form of brain aging—dementia—affects an estimated 50 million older individuals worldwide. Current treatments for cognitive decline and neurocognitive disorders include medications targeting amyloid β, phosphorylated tau, or chronic inflammation, cognitive training, physical exercise, brain–computer interface technologies, etc. These treatments are effective but never radical therapies. For this Special Issue, I would like to invite authors to submit studies focusing on the current and emerging treatment options in cognitive decline and neurocognitive disorders. Authors are welcome to cover other specific topics that have not been mentioned but fall within the theme of the Special Issue.
Prof. Dr. Yanxia Lu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cognitive decline
- neurocognitive disorder
- Alzheimer’s disease
- treatment
- brain aging